Vivos Therapeutics Dividends

VVOS Stock  USD 4.55  0.06  1.30%   
Dividends Paid is likely to drop to about 3 M in 2024. Dividend Paid And Capex Coverage Ratio is likely to drop to -15.62 in 2024. Vivos Therapeutics' past performance could be the main factor of why investors trade Vivos Therapeutics stock today. Investors should clearly understand every aspect of the Vivos Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Vivos Therapeutics' dividend schedule and payout information. Vivos Therapeutics dividends can also provide a clue to the current valuation of Vivos Therapeutics.
Last ReportedProjected for Next Year
Dividends Paid3.3 MM
Dividend Paid And Capex Coverage Ratio(14.88)(15.62)
One of the primary advantages of investing in dividend-paying companies such as Vivos Therapeutics is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Vivos Therapeutics must own a stock before its ex-dividend date to receive its next dividend.

Vivos Therapeutics Dividends Paid Over Time

Today, most investors in Vivos Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vivos Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Vivos Therapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period.
   Dividends Paid   
       Timeline  
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos Therapeutics. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.99)
Revenue Per Share
6.877
Quarterly Revenue Growth
0.194
Return On Assets
(0.57)
Return On Equity
(2.85)
The market value of Vivos Therapeutics is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vivos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos Therapeutics' market value can be influenced by many factors that don't directly affect Vivos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: